Rapport Therapeutics, Inc. (RAPP)
Healthcare
Biotechnology
41.00 $
-4.2%
vs. previous close
Closing price · As of: 31. Jul 2026
Rapport Therapeutics, Inc. (RAPP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -13 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.6 | -5.4 | -10 | -18 | -16 | -16 | -14 | -20 | -25 | -17 | -25 | -13 | -80 | |
| 0.0 | 0.0 | 0.1 | 0.2 | 0.2 | 0.2 | 0.3 | 0.2 | 0.3 | 0.3 | 0.3 | 0.2 | 1.0 | |
| 0.9 | 0.9 | 1.0 | 1.5 | 2.4 | 3.2 | 3.2 | 4.0 | 4.4 | 4.7 | 5.7 | 7.0 | 22 | |
| -1.2 | 2.3 | 1.9 | -3.2 | -0.1 | 3.3 | 1.3 | -0.4 | -3.4 | 3.7 | 3.6 | -0.8 | 3.2 | |
| 0.1 | 0.1 | 1.4 | 1.1 | 1.0 | 0.1 | 0.2 | 0.3 | 0.0 | 0.1 | 0.2 | 0.1 | 0.4 | |
| -0.1 | -0.1 | -79 | -42 | -107 | -53 | 32 | 21 | 23 | -57 | -174 | 38 | -171 | |
| – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -0.1 | 85 | -0.1 | 64 | 159 | -1.4 | 0.0 | 0.0 | -0.1 | 271 | 0.3 | 0.5 | 271 | |
| -6.8 | 80 | -89 | 4.1 | 36 | -71 | 17 | 0.8 | -2.5 | 196 | -199 | 25 | 20 | |
| -6.7 | -5.5 | -12 | -19 | -17 | -17 | -15 | -21 | -25 | -18 | -25 | -13 | -81 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.